BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24910429)

  • 1. Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5.
    Mazurek A; Park Y; Miething C; Wilkinson JE; Gillis J; Lowe SW; Vakoc CR; Stillman B
    Cell Rep; 2014 Jun; 7(6):1887-99. PubMed ID: 24910429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX5-targeting fully human monoclonal autoantibody inhibits proliferation and promotes differentiation of acute promyelocytic leukemia cells by increasing ROS production.
    Wu J; You YQ; Ma YX; Kang YH; Wu T; Wu XJ; Hu XX; Meng QH; Huang Y; Zhang N; Pan XB
    Cell Death Dis; 2020 Jul; 11(7):552. PubMed ID: 32690860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
    Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
    Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of DEAD-box RNA helicase DDX5 selectively attenuates serine 311 phosphorylation of NF-κB p65 subunit and expression level of anti-apoptotic factor Bcl-2.
    Tanaka K; Tanaka T; Nakano T; Hozumi Y; Yanagida M; Araki Y; Iwazaki K; Takagi M; Goto K
    Cell Signal; 2020 Jan; 65():109428. PubMed ID: 31626956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
    Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
    Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA helicase DDX5 supports mitochondrial function in small cell lung cancer.
    Xing Z; Russon MP; Utturkar SM; Tran EJ
    J Biol Chem; 2020 Jul; 295(27):8988-8998. PubMed ID: 32376686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
    Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
    Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun.
    Alhuthali HM; Bradshaw TD; Lim KH; Kam TS; Seedhouse CH
    BMC Cancer; 2020 Jul; 20(1):629. PubMed ID: 32635894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
    Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
    Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX5/p68 RNA helicase expression is essential for initiating adipogenesis.
    Ramanathan N; Lim N; Stewart CL
    Lipids Health Dis; 2015 Dec; 14():160. PubMed ID: 26637310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.
    Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.
    Huang S; Li C; Zhang X; Pan J; Li F; Lv Y; Huang J; Ling Q; Ye W; Mao S; Huang X; Jin J
    Mol Oncol; 2020 Oct; 14(10):2560-2573. PubMed ID: 32519423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
    Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
    J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
    J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
    Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
    Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress.
    Doshi KA; Trotta R; Natarajan K; Rassool FV; Tron AE; Huszar D; Perrotti D; Baer MR
    Oncotarget; 2016 Jul; 7(30):48280-48295. PubMed ID: 27374090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.